| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Humanized (from mouse) |
| Target | TACSTD1 |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 945228-49-9 |
| ATC code | None |
| UNII | 23J303Z5CA |
| Chemical data | |
| Formula | C3455H5371N921O1060S18 |
| Mol. mass | 77.3 kDa |
| (what is this?) (verify) |
|
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]